REYON PHARMACEUTICAL CO., LTD

Develops & makes APIs, generics, cell/gene therapies, and offers biopharma CDMO services.

102460 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 강남구 테헤란로 620 에이동 12층 (대치동, 미래에셋타워), 강남구
Website:: https://www.reyonpharm.co.kr/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Reyon Pharmaceutical Co., Ltd. is an integrated pharmaceutical company focused on the research, development, and manufacturing of both chemical and biopharmaceutical products. The company's core business includes the production of Active Pharmaceutical Ingredients (APIs) and finished generic formulations, such as injections, tablets, and antibiotics. Strategically expanding into next-generation therapeutics, Reyon is actively developing advanced treatments in areas like AAV gene therapy for conditions such as wet age-related macular degeneration (wAMD) and NK cell therapy for solid cancers. A significant part of its growth strategy involves its biopharmaceutical Contract Development and Manufacturing Organization (CDMO) services, which are being scaled through strategic partnerships to support the production of complex biologics.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for REYON PHARMACEUTICAL CO., LTD and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
2025-08-14 00:00	Interim Report 반기보고서 (2025.06)	Korean	2.5 MB

Automate Your Workflow. Get a real-time feed of all REYON PHARMACEUTICAL CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for REYON PHARMACEUTICAL CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
HYUNDAI BIOLAND Co.,Ltd. Develops natural biomaterials for cosmetics, nutraceuticals, and regenerative medicine globally.	South Korea	052260
Icure Pharmaceutical Incorporation Develops transdermal patches for dementia/Parkinson's and offers cosmetic ODM/OBM services.	South Korea	175250
Idorsia Ltd Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.	Switzerland	IDIA
IL DONG PHARMACEUTICAL CO., LTD. Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.	South Korea	249420
ILSUNG IS CO., LTD. Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.	South Korea	003120
ILYANG PHARMACEUTICAL CO.,LTD Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.	South Korea	007570
ImmuneOncia Therapeutics, Inc. A biopharma firm developing immune checkpoint inhibitors for cancer immunotherapy.	South Korea	424870
Immuno-Biological Laboratories Co., Ltd. Develops and supplies immunological reagents and diagnostics for research and drug discovery.	Japan	4570
Incanthera plc Develops targeted dermatology & oncology therapies using unique formulation & delivery technologies.	United Kingdom	N/A
Indivior PLC Develops pharmaceuticals for opioid use disorder, addiction, and serious mental illnesses.	United Kingdom	INDV